|
Ju-Xiang
Li, Department of Physiology and Pathophysiology, Health Science
Center, Peking University, Beijing 100083, China
Yong-Zheng Pang, Chao-Shu Tang, Institute of Cardiovascular
Research, First Hospital, Peking University, Beijing 100034, China
Zai-Quan Li, Department of Biochemistry and Molecular
Biology, Health Science Center, Peking University, Beijing 100083,
China
Supported by the Major State Basic Research Development
Program of People’s Republic of China, No. G2000056905 and the
National Natural Science Foundation of China, No. 30070308
Correspondence to: Zai-Quan Li, Department of Biochemistry
and Molecular Biology, Health Science Center, Peking University,
Beijing 100083, China. lizaiquan@bjmu.edu.cn
Telephone: +86-10-82801631
Fax: +86-10-66176255
Received: 2003-06-21
Accepted: 2003-08-16
Abstract
AIM: Taurine has been shown to be an effective scavenger of
hypochlorous acid (HOCl). The role of HOCl is well established in
tissue damage associated with inflammation and injury. In the
present study, the effect of HOCl on nuclear nucleoside
triphosphatase of hepatocytes and the ability of taurine to prevent
this effect were investigated.
METHODS:
Isolated hepatic nuclei from rat liver were exposed to HOCl with or
without taurine. The NTPase activity on nuclear envelope was assayed
using ATP and GTP as substrates, respectively.
RESULTS:
The first series of experiments evaluated the toxicity of HOCl and
the efficacy of taurine to protect NTPase. HOCl at 10-9-5×10-6
mol/L reduced nuclear NTPase activities in a concentration dependent
manner (ATP and GTP as substrates) (P<0.01). HOCl at 10-6
mol/L reduced the NTPase activity by 65% (ATP as substrate) and 76%
(GTP as substrate). Taurine (10-7 to 10-4
mol/L) was tested for protection against HOCl at 10-6
mol/L and the nuclei treated with 5×10-4
mol/L taurine exhibited only 20% and 12% reduction in NTPase
activities compared to untreated controls. A second study was
performed comparing taurine to glutathione (GSH). GSH and HOCl at 10-6
mol/L exhibited 46% and 67.4% reduction in NTPase activities
compared with control. GSH (10-4 mol/L) which was
incubated with the nuclei and HOCl still exhibited 44.2% and 44.8%
reduction in NTPase activities of untreated control. Taurine with
HOCl only exhibited 15.2% and 17.1% reduction in NTPase activities,
which provided more powerful protection against HOCl than GSH. The
third experiment was undertaken to evaluate the specificity of
taurine against HOCl. Incubation of rat hepatic nuclei with Fe3+/H2O2
(1 m mol/L vs 5
mmol/L)
resulted in a decrease in nuclear NTPase activities (P<0.01).
When hepatic nuclei were incubated with Tau (10-4 mol/L)
and Fe3+/H2O2 (1m mol/L vs 5
mmol/L),
nuclear NTPase activities were only slightly increased as compared
with that of incubation with Fe3+/H2O2
alone. However, GSH failed to alter the NTPase activities induced by
Fe3+/H2O2.
CONCLUSION:
The present findings indicate that HOCl can act as an inhibitor of
nuclear NTPase. Taurine can antagonistically reduce the toxicity of
HOCl to NTPase.
Li
JX, Pang YZ, Tang CS, Li ZQ. Protective effect of taurine on
hypochlorous acid toxicity to nuclear nucleoside triphosphatase in
isolated nuclei from rat liver. World J Gastroenterol
2004; 10(5): 694-698
http://www.wjgnet.com/1007-9327/10/694.asp
INTRODUCTION
The mechanism of mRNA transport involves two major steps: the
recognition of RNA molecules to be transported and their transfer
through the nuclear pore. The latter step is an important
rate-limiting step in protein expression[1]. The
nucleocytoplasmic transport of mRNA is an energy-consuming process.
The energy requirement is associated with the functioning of a
nucleoside triphosphatase (NTPase). The nuclear NTPase activity
exhibits a broad substrate specificity toward nucleotides and
divalent metal cations[2,3]. The recent data demonstrated
that the activity of the NTPase was strikingly inhibited by
cholesterol oxidase treatment, which indicated that oxidation of
nuclear membrane cholesterol could inhibit NTPase activity[4].
These results have implications for mRNA flux across the nuclear
membrane during conditions where lipid peroxidation may be expected.
Hypochlorous
acid (HOCl) is a major oxidant produced by neutrophils and monocytes,
via the myeloperoxidase-catalyzed oxidation of chloride by hydrogen
peroxide[5]. HOCl is a potent oxidant capable of damaging
host tissue during inflammation. The strong oxidizing species HOCl
plays a highly significant role in the bactericidal function of the
neutrophil. However, inappropriate and/or excessive activation of
neutrophils leads to oxidative stress and collateral damage to
surrounding tissues. Cysteine and methionine residues in proteins
and reduced glutathione (GSH) appear to be the main targets for HOCl[6],
thereby altering the structure and function of proteins and lowering
antioxidant status in the cell. In the literature, taurine, a
2-amino ethanesulfonic acid, is characterized as an antioxidant, a
membrane protector, or a regulator of calcium ion homeostasis. It is
the major free intracellular amino acid that presents in many
tissues[7,8] and possibly acts physiologically as a trap
for HOCl[8]. In the present study, we explored the
possible action of HOCl on hepatic nuclear NTPase activity and the
protective effect of taurine on the changes of NTPase activity
induced by HOCl.
MATERIALS
AND METHODS
Materials
Male Sprague-Dawley (SD) rats were supplied by the Animal
Center, Health-Science Center, Peking University. Taurine and GSH
were purchased from Sigma Chemical Co (St. Louis, MO, USA). The term
HOCl was used to cover the equilibrium mixture with OCI- present at
neutral pH. The following reagents were freshly prepared.
Phenylmethylsulfonyl fluoride (PMSF), sodium salt of nucleotides
(ATP and GTP); DS/PMSF buffer (mmol/L): 250 sucrose, 50 Tris/HCl pH
7.4, 5 MgCl2, 1 PMSF; STM/ Buffer (mmol/L): 2 100
sucrose, 50 Tris/HCl pH 7.4, 5 MgCl2, 1 PMSF, 1 EDTA, l
DTT, and l mmol/L
leupeptin. All the reagents were analytically pure.
Isolation
of rat hepatocytes
Rat hepatocytes were isolated according to Berry and Friend
methods[9]. Briefly, under anesthesia with urethane (1
g/kg i.p.), male SD rats (220-250 g) were in situ liver-perfused at
37 °C via portal vein,
with Ca2+-free Hanks’ solution containing 5 mg/L
collagenase and 1 mg.L-1 hyaluronidase bubbling of 950
ml/L O2-50 ml/L CO2. After 20 min perfusion,
the liver was removed, transferred to a beaker containing 200 mL of
enzyme medium, broken up with a blunt spatula, and shaken at 37 °C for 15 min in an
atmosphere of air. The suspension was filtered through nylon mesh
and the cells were separated from debris by centrifuging at 50 g for
2 min. The cells were resuspended in Hanks’ solution at 4 °C. Cell viability
tested by trypan blue exclusion was higher than 90%.
Isolation
and chracterization of hepatic nuclei
Isolation of rat liver nuclei was performed according to the
method described by Kaufmann et al[10] with
modification. Suspended cells were homogenized in Teflon (10
strokes), sedimented at 800 r/min for 10 min. The nuclei were
suspended in DS/PMSF buffer, layered over cushions of this buffer,
and sedimented at 70 000 g for 60 min. Isolated nuclei were
resuspended in STM/PMSF buffer, again layered over cushions of DS/PMSF
buffer, and sedimented at 70 000 g for 30 min. The final pellet was
resuspensed with STM/PMSF to 1 mg protein/mL, and stored at -70 °C.
Nuclear
membrane NADH pyrophosphorylase activity and microsome- NADPH
cytochrome-C reductase activity were determined to test the
purification of the freshly isolated hepatocyte nuclei.
Protocol
for treatment of isolated nuclei with hypochlorous acid and taurine
Isolated purified nuclei (0.25 mL) were incubated with
different chemicals (dissolved in 0.25 mL) for 10 min at 30 °C. The reaction was
stopped by cold (4 °C) centrifugation on
microcentrifuge for 2 min, and the nuclei pellet was washed once and
then resuspended in STM/PMSF to obtain a final protein concentration
of 1 mg/mL.
Protocol 1: incubation with buffer alone (control) and sodium
hypochlorite (10-9 to 5×10-6
mol/L), respectively. Protocol
2: Incubation with buffer alone (control), taurine (10-6,
10-5 and 10-4 mol/L), sodium hypochlorite (10-6
mol/L), sodium hypochlorite (10-6 mol/L) plus taurine (10-7
to 10-4 mol/L), respectively. Protocol 3: Incubation with
sodium hypochlorite (10-6 mol/L), sodium hypochlorite (10-6
mol/L) plus glutathione (GSH, 10-6 to 10-4
mol/L), respectively. Protocol 4: Incubation with buffer alone
(control), taurine (10-4 mol/L), GSH (10-4
mol/L), H2O2/FeSO4 (1m mol/L/5 mmol/L),
H2O2/FeSO4 (1 mmol/L/5 mmol/L)
plus taurine (10-6 to 10-4 mol/L), H2O2/FeSO4
(1 m mol/L/5 mmol/L)
plus GSH (10-6 to 10-4 mol/L), respectively.
Assay
of nuclear NTPase activity
NTPase activity was assayed as described by Tiffany[11]
and Ramjiawan[12] with modification. Nuclear suspension
(1 mg
protein/mL)
was preincubated for 10 min at 30 °C. Addition of 1.0
mmol/L ATP or 1.0 mmol/L GTP initiated the reaction. Ten minutes
after 30 °C-incubation, the
reaction was stopped by addition of 100g/L SDS and placing the test
tube on ice bath, and inorganic phosphate was measured according to
the method of Raess[13], which was expressed as nmol/mgPr
per 10 min. Preliminary experiments showed a linear relationship of
NTPase activity with incubation time of nucleoside triphosphate
within 30 min. The values were normalized to protein content.
Data
analysis
Separated six experiments were performed in duplicate. All
results were expressed as mean±SD. Statistical analysis of the data
was performed using one-way analysis of variance followed by
Student-Newman-Keuls tests. P<0.05 was accepted as
statistically significant.
RESULTS
Characterization of hepatic nuclei
The
level of NADH pyrophosphorylase activity (as marker enzyme for
nuclear envelope) in prepared nuclei from rat hepatocytes was 7-fold
that in homogenate of whole cells (25.77±1.26 vs 3.68±0.27 nmol/mg Pr per min, P<0.01), but NADPH cytochrome C
reductase activity (marker enzyme for microsome) was only 28% of
that in hypatocytes homogenate (2.88±0.22 vs 10.27±0.87 nmol/mg Pr per min, P<0.01). While the activity of
mannose-6-phosphatase existing in both microsomes and nuclei, was
4-5 times that in cell homogenate (412±22 vs 91±6 nmol/mg Pr per min, P<0.01). It showed that the isolated
hepatic nuclear fraction was of high purity and little contaminated
by other organelles.
Inhibitory
effect on hepatic nuclear NTPase of hypochlorous acid
HOCl
(at mol/L: 10-9-5×10-6) could significantly depress NTPase activity of hepatic
nuclei in a concentration- dependent manner, regardless ATP or GTP
as a substrate (Figure 1). After incubation of hepatic nuclei with 5×10-6
mol.L-1 HOCl, the hepatic nuclear NTPase activities were
decreased by 70.0% (ATP as substrate) and by 76.3% (GTP as
substrate), compared with those of control groups (both P values
less than 0.01) respectively.
Figure
1(PDF) Inhibitory effect
of hypochlorous acid on hepatic nuclear NTPase activity. ATP and GTP
were used as reaction substrates, respectively. Mean±SD, n=6.
aP<0.05, bP<0.01
compared with control.
Effects
of taurine on hepatic nuclear NTPase activity
The effect of taurine on NTPase activity is shown in Table
1. After incubation of hepatic nuclei with different concentrations
of taurine (10-6, 10-5 and 10-4
mol/L), the NTPase activities on nuclear envelope were increased in
a concentration-dependant fashion, either using ATP or GTP as a
substrate (all P values <0.05 as compared with those of
controls). When taurine was at 10-4 mol/L, the NTPase
activities were increased by 18.1% (ATP as substrate) and 27.3% (GTP
as substrate), respectively. All P values were less than 0.01 as
compared with those of their controls.
Table
1 Effects of
taurine on hepatic nuclear NTPase activity
| Groups |
NTPase
activity (nmol/mg Pr per 10 min) |
| ATP
as substrate |
GTP
as substrate |
| Control |
127±7 |
150±9 |
| Taurine
10-6 mol/L |
136±9
(+7.1%) |
168±10(+12.0%)a |
| Taurine
10-5 mol/L |
148±7
(+16.5%)b |
179±11(+19.3%)b |
| Taurine
10-4 mol/L |
150±8
(+18.1%)b |
191+12 (±27.3%)b |
ATP
and GTP were used as reaction substrates, respectively. The
increases of the enzyme activities are indicated in parentheses as
percentage of the control. Mean±SD, n=6. aP<0.05,
bP<0.01 compared with control.
Effect
of taurine on OCl--induced inhibition of hepatic nuclear NTPase
activity
The abilities of HOCl to depress NTPase were confirmed by
detecting NTPase activities. Incubation of hepatic nuclei with HOCl
at 10-6 mol.L-1 resulted in an obviously lower
nuclear NTPase activity than that with buffer alone. The hepatic
nuclear NTPase activities were decreased by 65.4% (ATP as substrate)
and by 76.0%(GTP as substrate), compared with the control groups
respectively (P<0.01).
The reduction of NTPase activities induced by HOCl was
antagonized by taurine (as shown in Figure 2), even at a very low
concentration (10-6 mol/L) (ATP and GTP as substrates).
The antagonistic effect of taurine on HOCl was in a concentration
dependent manner. When the nuclei were incubated with HOCl (10-6
mol/L) and taurine (5×10-4
mol/L), the NTPase activity reached 80.3% (ATP as substrate) and
88.7% of control group (GTP as substrate), respectively (all
P values less than 0.01).
Figure
2(PDF)
Effect of taurine
on OCl--induced inhibition of NTPase activity in hepatic nuclei. ATP
and GTP were used as reaction substrates, respectively. Mean±SD, n=6.
aP<0.05, bP<0.01 compared
with OCl (10-6 mol/L) group. cP<0.05,
dP<0.01 compared with control.
Effect
of glutathione on OCl--induced inhibition of hepatic nuclear NTPase
activity
Incubation of hepatic nuclei with HOCl at 10-6
mol/L resulted in an obviously lower nuclear NTPase activity. The
hepatic nuclear NTPase activities were decreased by 51.2% (ATP as
substrate) and by 101.3% (GTP as substrate), compared with the
control groups respectively (P<0.01). The reduction of
NTPase activities induced by HOCl was antagonized by taurine (10-4
mol/L, ATP and GTP as substrates). Incubation of taurine increased
the NTPase activity by 92.6% (ATP as substrate) and 154% (GTP as
substrate) compared with HOCl incubation (as shown in Figure 3). GSH
incubation attenuated the depressive effect of HOCl in a
concentration- dependent manner. When the nuclei were incubated with
HOCl (10-4 mol/L) and GSH (10-4 mol/L), the
NTPase activity was increased by 27% (ATP as substrate) and 38.5% (GTP
as substrate) of HOCl incubation group, respectively (all P values
less than 0.01). It was showed that the effect of GSH on HOCl-induced
depression of NTPase was smaller than that of taurine (F value: 5.3,
P<0.01).
Figure
3(PDF) Effects of
glutathione on OCl--induced inhibition of NTPase activity in hepatic
nuclei. ATP and GTP were used as reaction substrates, respectively.
Mean±SD, n=6. bP<0.01 compared with control group
(OCl-1 10-6 mol/L). aP<0.05,
cP<0.01 compared with (10-6 mol/L
OCl-1+10-4 mol/L taurine).
Effect
of taurine and GSH on .OH-induced inhibition of hepatic nuclear
NTPase activity
The ability of the Fe3+-H2O2
system to produce .OH was confirmed by detecting NTPase activities.
Incubation of hepatic nuclei with Fe3+-H2O2
at 1 m mol/L/5 mmol/L
resulted in a lower nuclear NTPase activity as compared with buffer
alone. The NTPase activities on nuclear envelopes were decreased by
70% (ATP as substrate) and by 76.7% (GTP as substrate), compared
with control group respectively (Table 2).
The reduction of NTPase activities induced by Fe3+-H2O2
was antagonized by taurine. When taurine was at 10-4
mol/L (ATP as substrate), the decreases of NTPase activities induced
by Fe3+-H2O2 (1 m mol/L/5 mmol/L)
were slightly reversed (from 29.8±8.2
to 46.5±8.7,
P<0.05). Whereas, GSH, at all concentrations used in our
experiment, had no significant effect on Fe3+-H2O2
-induced depression of NTPase activity (Table 2).
Table
2 Effect of taurine
and glutathione on .OH -induced inhibition of NTPase activity in
hepatic nuclei
| Groups |
NTPase
activity (nmol/mg Pr per 10 min) |
| ATP
as substrate |
GTP as substrate |
| Control |
100.0±9.9 |
151.8±9.9 |
| Tau
(10-4 mol/L) |
138±14.6 |
175.5±5.9 |
| GSH
(10-4 mol/L) |
95±12.2 |
150.0±9.8 |
| .OH |
29.8±8.2b |
35.3±7.8b |
| .OH+Tau
(10-6 mol/L) |
35.6±6.1 |
36.2±8.8 |
| .OH+Tau
(10-5 mol/L) |
40.8±8.8 |
32.7±7.3 |
| .OH+Tau
(10-4 mol/L) |
46.5±8.7a |
43.3±7.2 |
| .OH+GSH
(10-6 mol/L) |
32.0±8.2 |
43.2±11.8 |
| .OH+GSH
(10-5 mol/L) |
32.1±9.7 |
41.2±9.6 |
| .OH+GSH
(10-4 mol/L) |
44.3±6.2 |
39.8±5.9 |
ATP
and GTP were used as reaction substrates, respectively. .OH was produced by Fenton chemistry (Fe3+-H2O2:
1 m mol/L/5 mmol/L).
Mean±SD, n=6. Tau: taurine, GSH: glutathione. bP<0.01
compared with control group (OCl-1 10-6 mol.L-1). aP
<0.05 compared with .OH (Fe3+-H2O2:
1 mmol/L/5 mmol/L)
group.
DISCUSSION
Nuclear NTPase, a nuclear membrane-associated enzyme, provides
energy for poly (A)+mRNA export through the nuclear pore. Many
factors may play a modulatory role in NTPase activity. Extracellular
biological active molecules, such as insulin, epidermal growth
factor and nuclear membrane cholesterol, could affect NTPase
activities through the individual cellular signal transduction
system[14]. In addition, oxygen derived free radicals of
nuclear membrane cholesterol could inhibit nucleoside triphosphatase
activity[4]. Thus, export of poly (A) mRNA from the
nucleus via the nuclear pore complex was influenced, which plays a
crucial role in protein synthesis[1-3, 14].
In this present study using nuclei purified from rat
hepatocytes, HOCl was confirmed to be a very efficient inhibitor of
nuclear NTPase activity. Hepatic nuclear NTPase activity was
depressed by incubation of hepatic nuclei with HOCl in a
concentration dependent manner, regardless of using ATP or GTP as
substrate. It was suggested that NTPase was one of the favorite
targets of HOCl. The inhibition of this enzyme might probably be
caused by oxidation of an amino acid critical for enzyme function.
It is difficult to determine the exact concentration of HOCl that
can be reached in vivo since it is formed locally and HOCl is very
reactive. Concentrations of the drugs in the present study were not
quite inadequately used. In our experiments, taurine and GSH were
present which might repair the oxidative damage to the NTPase.
Therefore the inhibition of nuclear NTPase activity in vitro was
reversible. Furthermore, taurine has been found to be an activator
for nuclear NTPase, since it could stimulate hepatic nuclear NTPase
activity in a concentration dependent manner. Taurine and thiol
group-containing compounds could play a protecting role during
inflammatory processes.
The mechanisms of the effect of HOCl were not concerned in
the present studies. It has been shown that HOCl is highly reactive
with a wide range of biological molecules[15,16]. Of
these, thiols are among the most reactive and crucial targets for
oxidation in a cell. The deleterious effects of HOCl could be
prevented by incubating the nuclei with thiol group-containing
compounds as glutathione in the present study. This was in perfect
agreement with Pullar et al[6] who reported that
HOCl could react rapidly with thiol groups. The initial product of
oxidation of thilos by HOCl was sulfinyl chloride[17]. It
could react with additional thiols to give disulfide[17].
Oxidation of sulfhydryl groups in proteins might affect their
functional properties. Formation of protein disulfides, mixed
disulfides with GSH, or sulfinic acids could result in changes in
enzymatic activity, conformation or affinity toward other molecules.
Such changes could contribute to the cell damage caused by oxidative
stress[18].
As
an antioxidant, taurine could effectively antagonize the toxic
effect of HOCl on NTPase. However, the mechanism of this effect
remains unclear. More recent information has revealed that taurine
could interact with peroxide anions to form stable products TauCl[8].
The latter was the product formed through the sequestration of
taurine with HOCl and has been found to be an exceptionally stable
and long-lived compound with cytoprotective properties due to its
ability to preserve cellular function in response to physiologic
stress[7]. In the present study, taurine greatly
inhibited the suppression of hepatic nuclear NTPase activity induced
by OCl-, indicating the important protective role of taurine against
OCl- attack.
It
has been found that oxygen free radical species such as H2O2
and O2 are produced in mammalian cells during normal
aerobic metabolism[19,20]. However, O2 or H2O2
dose not directly act under physiologically relevant conditions. It
has been proposed that much of the toxicity of these species in
living organisms be due to the iron-dependent generation of .OH, and
/or other powerful oxidants, by Fenton chemistry[21].
Once it oxidizes Fe2+, the reactive .OH is produced.
Incubation of hepatic
nuclei with Fe3+-H2O2 in the
present study resulted in the decrease of NTPase activities in a
concentration dependent manner both using ATP and GTP as substrates,
which was coincident with that of Ramjiawan’s work[4].
The results of this in vitro study demonstrated that neither taurine
nor GSH could directly prevent the reduction of nuclear NTPase
activity caused by the .OH producing Fe3+/H2O2
system, even if very high concentrations of them (10-4
mol.L-1) were used regardless of using ATP or GTP as
substrate. These results therefore suggested that taurine could
protect NTPase from HOCl specifically.
It
has been found that HOCl is produced under aerobic and
pathophysiological conditions such as oxidative stress and
inflammation[22]. Under most circumstances, HOCl is
likely to be the major strong oxidant produced by neutrophils, and
contributors to oxidative damages associated with a variety of
diseases in which inflammatory cells participate[23].
Impairment of NTPase on hepatic nuclei by HOCl might result in
default of RNA nucleocytoplasmic transport. Taurine could antagonize
the toxic effect of HOCl on NTPase. This observation could be a part
of the global machinery, which acts as a cytoprotective factor in
liver inflammation and oxygen stress.
In
summary, our results showed that HOCl could cause a decrease in
nuclear NTPase activities, which was most likely the result of
decreased breakdown of NTPase. This pointed toward HOCl as an
inhibitor of this enzyme. Nuclear NTPase can be effectively
protected by taurine against HOCl driven oxidative injury, a
consequence of direct drug scavenging capacity towards HOCl.
Interaction of taurine with HOCl can also protect nuclear NTPase
activity. Therefore, taurine treatment would have a beneficial
effect on some diseases relating to protein synthesis.
REFERENCES
1
Izaurralde E, Mattaj IW. RNA export. Cell 1995; 81: 153-159
2
Tomassoni ML, Amori D, Magni MV. Changes of nuclear membrane
lipid composition affect RNA nucleocytoplasmic
transport. Biochem Biophys Res Commun
1999; 258: 476-481
3
Agutter PS. Influence of nucleotides, cations and nucleoside
triphosphatase inhibitors on the release of ribonucleic acid
from isolated rat liver nuclei.
Biochem J 1980; 188: 91-97
4
Ramjiawan B, Czubryt MP, Massaeli H, Gilchrist JS, Pierce GN.
Oxidation of nuclear membrane cholesterol inhibits
nucleoside triphosphatase activity.
Free Radic Biol Med 1997; 23: 556-562
5
Winterbourn CC, Vissers MC, Kettle AJ. Myeloperoxidase. Curr
Opin Hematol 2000; 7: 53-58
6
Pullar JM, Winterbourn CC, Vissers MC. Loss of GSH and thiol
enzymes in endothelial cells exposed to sublethal
concentrations of hypochlorous acid.
Am J Physiol 1999; 277(4 Pt 2): H15051512
7
Lourenco R, Camilo ME. Taurine: a conditionally essential
amino acid in humans? An overview in health and disease.
Nutr Hosp 2002; 17: 262-270
8
Huxtable RJ. Physiological actions of taurine. Physiol Rev
1992; 72: 101-163
9
Berry MN, Friend DS. High-yield preparation of isolated rat
liver parenchymal cells. J Cell Biol 1969; 43: 506-520
10
Kaufmann SH, Gibson W, Shaper JH. Characterization of the
major polypeptides of the rat liver nuclear envelope. J Biol
Chem 1983; 258: 2710-2719
11
Tiffany BR, White BC, Krause GS. Nuclear-envelope nucleoside
triphosphatase kinetics and mRNA transport following
brain ischemia and reperfusion. Ann
Emerg Med 1995; 25: 809-817
12
Ramjiawan B, Czubryt MP, Gilchrist JS, Pierce GN. Nuclear
membrane cholesterol can modulate nuclear nucleoside
triphosphatase activity. J Cell
Biochem 1996; 63: 442-452
13
Racess BU, Vincenzi FF. A semi-automated method for the
determination of multiple membrane ATPase activities. J
Pharmacol Methods 1980; 4: 273-283
14
Schroder HC, Wenger R, Ugarkovic D, Friese K, Bachmann M,
Muller WE. Differential effect of insulin and epidermal
growth factor on the mRNA
translocation system and transport of specific poly (A+) mRNA and
poly (A-) mRNA in
isolated nuclei. Biochemistry 1990;
29: 2368-2378
15
Prutz WA. Hypochlorous acid interactions with thiols,
nucleotides, DNA, and other biological substrates. Arch Biochem
Biophys 1996; 332: 110-120
16
Prutz WA, Kissner R, Koppenol WH, Ruegger H. On the
irreversible destruction of reduced nicotinamide nucleotides by
hypohalous acids. Arch Biochem
Biophys 2000; 380:
181-191
17
Peskin AV, Winterbourn CC. Kinetics of the reactions of
hypochlorous acid and amino acid chloramines with thiols,
methionine, and ascorbate. Free Radic
Biol Med 2001; 30: 572-579
18
Sen CK, Packer L. Antioxidant and redox regulation of gene
transcription. FASEB J 1996; 10: 709-720
19
Jaeschke H. Mechanisms of oxidant stress-induced acute tissue
injury. Proc Soc Exp Biol Med 1995; 209: 104-111
20
Simpkins CO. Metallothionein in human disease. Cell Mol Biol
2000; 46: 465-488
21
Halliwell B, Gutteridge JM. Role of free radicals and
catalytic metal ions in human disease: an overview. Methods
Enzymol 1990; 186: 1-85
22
Bomzon A, Ljubuncic P. Oxidative stress and vascular smooth
muscle cell function in liverd isease. Pharmacol Ther
2001; 89: 295-308
23
Winterbourn CC, Kettle AJ. Biomarkers of myeloperoxidase-derived
hypochlorous acid. Free Radic Biol Med
2000; 29: 403-409
Edited
by Wang
XL Proofread by Zhu LH
| |